Results 1-4 of 4 for drugs segment:8856138

Ceisteanna - Questions: Cabinet Committees (5 Mar 2024)

Paul McAuliffe: ...pursue without continuously saying "Yes" to pharma companies, and not resorting to patients having to advocate in the way that we do. We have to have a more humane version of the HTA process. The drugs that are put through that process have to be more available to patients while, at the same time, we seek to secure the best value for money for the taxpayer.

Ceisteanna - Questions: Cabinet Committees (5 Mar 2024)

Paul Murphy: I want to ask about a pretty pressing issue for underfunded community drugs projects, namely, the extortionate cost of insurance. I will give a couple of examples from Tallaght to show just what an impact this is having. One project was paying €2,500 six years ago for insurance. That increased to just over €6,000 three years ago. For 2023, the insurance company wanted...

Ceisteanna - Questions: Cabinet Committees (5 Mar 2024)

Leo Varadkar: ...teams and community support teams are now in place and are providing care closer to home. We are also making healthcare more affordable, at a time when the cost-of-living crisis is affecting everyone, through the removal of hospital inpatient charges, widened eligibility for the GP card and a reduced drug payment scheme threshold, among other things. Tá níos mó ná...

Ceisteanna - Questions: Cabinet Committees (5 Mar 2024)

Pádraig O'Sullivan: .... We have spoken about it before and I welcome its publication, but the reality is that the report will not meaningfully reduce the times for which people are waiting for the approval of an orphan drug. When this Government took office, there was an average of more than 900 days for a drug to be approved through the HTA process. When this Government finishes office, which will be any...